VEGFA and vitreous hemorrhage: A meta-analysis has also shown that anti-VEGF pretreatment 6–14 days prior to vitrectomy in DR patients can reduce operation time, improve postoperative best-corrected visual acuity (BCVA), and decrease the recurrence rate of vitreous hemorrhage (51).